Atrandi Biosciences
Atrandi Biosciences is breaking new ground in high-throughput analysis technologies.
Atrandi Biosciences has raised €24M across 1 funding round from 5 investors, most recently a Series A round in Feb 2025. Based in Vilnius, Lithuania; active in Healthtech. Data as of 28 Oct 2026.
Vilnius, Lithuaniawww.atrandi.com ↗
Total raised
€24M
€23,960,130
Funding rounds
1
Investors
5
distinct backers
Active since
2025-02
latest 2025-02
Funding by year
EUR raised per yearAtrandi Biosciences — funding by year — interactive chart.
Data table
| Atrandi Biosciences — funding by year | |
|---|---|
| 2025 | €24M |
Signals
High confidenceRaise-next likelihood61
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-19 | Series A | €24M | GRIDS Capital,Lux Capital,Metaplanet,Practica Capital,Vsquared Ventures | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Vinted€817MLithuania · Fashion
Global coverage: FundingData